Asuragen Molecular Diagnostics Publications

Asuragen has researched and published extensively in genetics, oncology, molecular diagnostics, and technology advancements for over 15 years. These publications, posters, and white papers cover various disease areas and their related genes including fragile X (FMR1), spinal muscular atrophy (SMN1/SMN2), cystic fibrosis (CFTR), and chronic myeloid leukemia (BCR-ABL1). They show the power of detecting and interpreting molecular alterations using AmplideX and QuantideX technologies as well as the value of Armored RNA controls and companion diagnostics collaborations to deliver new insights and advance precision medicine. Simply search by term, filter by category, or use both to find your area of interest.

We’re driven to provide people with better answers, so we ensure our products are supported by reliable data and backed by rigorous science. Dive into these publications to learn more.

Comparison of the QuantideX® qPCR BCR-ABL IS Kit and the modified EAC protocol for the monitoring of major molecular response in CML patients.
Ruhksaar Ali - Presented at the John Goldman Conference on CML
A novel repeat-primed PCR assay to detect the full range of trinucleotide CAG repeats in Huntingtin gene (HTT)
Asuragen collaboration with Istituto CSS-Mendel - Presented at ESHG
Accurate Single-Tube Quantification of SMN1 and SMN2 Copy Numbers Using a Rapid and Streamlined PCR/CE Assay Evaluated at Two Different Laboratories
Asuragen collaboration with centro hospital de Porto - Presented at ESHG
Absence of AGG interruptions is a risk factor for a full mutation expansion among ethnically diversed FMR1 premutation carriers
Asuragen collaboration with Tel Aviv University - Presented at ESHG
Analytical Validation of a Sensitive Myotonic Dystrophy Type 1 (DM1) Diagnostic Test That Provides Precise Repeat Sizing and Resolves Zygosity in a Single PCR
Gary Latham, Ph.D. - Presented at ESHG
Using Armored RNA®/DNA as Reliable Molecular Controls in Infectious Disease Testing and Beyond
Deepa Eveleigh - Presented at ASM CVS
Evaluation of the AmplideX® PCR/CE HTT Kit for the Rapid and Accurate Genotyping of CAG Repeat Expansions
Darshana Patel - Presented at ACMG
Two-site Evaluation of a Rapid, Multiplexed PCR/CE Assay for Assessment of Spinal Muscular Atrophy SMN1 and SMN2 Copy Number Status
Stela Filipovic-Sadic - Presented at ACMG
A Machine-Learning Framework for Accurate Classification and Quantification of Oncogenic Variants Using the QuantideX® NGS DNA Hotspot 21 Kit
Lando Ringel - Presented at AMP
Analytical Validation Of The QuantideX® NGS DNA Hotspot 21 Kit, A Diagnostic NGS System for the Detection of Actionable Mutations in FFPE Tumors
Kevin Kelnar - Presented at AMP
Search
Filter

Publication Categories

Publication Types

Clear All Filters
Back To
Top